1. Home
  2. NVAX vs LNN Comparison

NVAX vs LNN Comparison

Compare NVAX & LNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Novavax Inc.

NVAX

Novavax Inc.

HOLD

Current Price

$9.25

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Logo Lindsay Corporation

LNN

Lindsay Corporation

HOLD

Current Price

$136.64

Market Cap

1.4B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
NVAX
LNN
Founded
1987
1954
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.4B
IPO Year
1996
1995

Fundamental Metrics

Financial Performance
Metric
NVAX
LNN
Price
$9.25
$136.64
Analyst Decision
Hold
Hold
Analyst Count
9
1
Target Price
$10.78
$128.00
AVG Volume (30 Days)
3.8M
60.5K
Earning Date
04-07-2026
04-09-2026
Dividend Yield
N/A
1.09%
EPS Growth
77.26
12.81
EPS
2.53
1.54
Revenue
$682,162,000.00
$676,368,000.00
Revenue This Year
$58.91
N/A
Revenue Next Year
N/A
$5.91
P/E Ratio
$3.68
$88.17
Revenue Growth
N/A
11.41
52 Week Low
$5.01
$106.10
52 Week High
$10.63
$149.56

Technical Indicators

Market Signals
Indicator
NVAX
LNN
Relative Strength Index (RSI) 58.44 67.30
Support Level $8.01 $134.72
Resistance Level $10.42 $142.73
Average True Range (ATR) 0.55 4.64
MACD 0.01 0.10
Stochastic Oscillator 79.50 45.28

Price Performance

Historical Comparison
NVAX
LNN

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.

About LNN Lindsay Corporation

Lindsay Corp provides proprietary water management and road infrastructure products and services. It manufactures and distributes agricultural irrigation equipment through two segments: Irrigation and Infrastructure. The Irrigation segment makes center pivot, lateral move, and hose reel irrigation systems and parts. The Infrastructure segment produces barriers, crash cushions, road marking and safety equipment, and railroad signals. The majority of revenue is from the Irrigation segment. The company operates in the United States and international markets, with the majority of revenue coming from the United States.

Share on Social Networks: